Prof. Mark Lowdell University College London, UK

Professor Mark Lowdell PhD FRCPath FRSB is the Professor of Cell & Tissue Therapy at University College London and Director of the Centre for Cell, Gene & Tissue Therapeutics / Honorary Consultant Immunologist at Royal Free Hospital London. He is a qualified diagnostic immunopathologist as well as holding MHRA Qualified... read morePerson status for the release of ATMPs for clinical trials. He held the post of Vice President (Europe) of the International Society for Cell & Gene Therapy for two terms from 2014-2018. Mark has over 25 years’ experience in adoptive immunotherapy of cancer and has targeted the role of the innate immune responses; especially the role of natural killer (NK) cells, although his experience includes a variety of adoptive T cell therapies (cancer and viral infection) as well as dendritic cell vaccines and CAR-T cells. He has focused particularly on translational research and established the first academic GMP facility in the UK for the production of human cells as medicines in 2003. Professor Lowdell has held and holds numerous appointments to academic and government advisory boards in the UK and overseas. Recently he was a member of the UK Government Regenerative Medicine Expert Review Group.